|
WELCOME TO NEOSTEM®

It is such an exciting time to be exploring the world of stem cells. In the following text and corresponding web pages, you will find a wealth of information regarding stem cells: what they are, how they work, and the potential and actual benefits they provide in our modern medical world.
At NeoStem®, we take great pride in the fact that we are the first to provide adult stem cell collection and storage services to the general adult population. We collect your own stem cells for your personal use should you need them to treat diseases you may develop.
As an adult, you are faced with many medical choices throughout your life and storing your stem cells is one choice most of us should consider. Your stem cells have shown remarkable promise in fighting off disease and in regenerating and repairing damaged tissue and cells in your body.
In the last several years, there have been many promising results in clinical trials utilizing a person's own stem cells in wound healing and bone reconstruction treatments, and in treating diseases such as lupus, multiple sclerosis, scleroderma, cancers, diabetes, heart disease, and many more. In fact, adult stem cells have been in use for the last 40 years in treating blood cancers. Most of you have heard of this treatment as a bone marrow transplant. In essence, a bone marrow transplant is a stem cell transplant.
Neostem is developing our therapeutics business in the adult stem cell field to capitalize on the increasing role adult stem cells are playing in regenerative medicine, with an initial focus on cardiac, orthopedic, wound, cosmetic and dermatologic indications. We are building our portfolio of stem cell therapeutics through a combination of product licenses and research and development. China's regulatory environment and culture are more accepting of new stem cell-based therapies than those in many other countries and our expansion into China reflects our belief that this market affords a unique opportunity to grow our revenues on an accelerated basis. Over the past year alone, we obtained three licenses to products and delivery technologies using adult stem cells that we believe offer near-term revenue potential in China and long-term potential in the U.S. once we have met the necessary development and regulatory requirements.
As you continue to explore this site, you will be exploring an opportunity that could very well change the future of your health.
Thank you for your interest in NeoStem®, and congratulations on taking a proactive approach to your health and longevity.
Robin L Smith, M.D., MBA Chairman and CEO
|